Docking and QSAR Studies of 1,4-Dihydropyridine Derivatives as Anti- Cancer Agent.

Mollazadeh, Shirin; Shamsara, Jamal; Iman, Maryam; Hadizadeh, Farzin

Mollazadeh, Shirin; Shamsara, Jamal; Iman, Maryam; Hadizadeh, Farzin.

Affiliation

Mollazadeh S; Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad. Iran.
Shamsara J; Pharmaceutical Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad. Iran.
Iman M; Department of Pharmaceutics, School of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Hadizadeh F; Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Recent Pat Anticancer Drug Discov ; 12(2): 174-185, 2017.

Article in En | MEDLINE | ID: mdl-28137213

Subject(s)

Antineoplastic Agents/pharmacology; Dihydropyridines/pharmacology; Drug Design; Neoplasms/drug therapy; Antineoplastic Agents/chemical synthesis; Antineoplastic Agents/chemistry; Dihydropyridines/chemical synthesis; Dihydropyridines/chemistry; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Least-Squares Analysis; Linear Models; Models, Molecular; Molecular Docking Simulation; Neoplasms/pathology; Quantitative Structure-Activity Relationship

Key words

ATP binding cassette; P-glycoprotein; QSAR; dihydropyridine; docking; multidrug resistance

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dihydropyridines / Drug Design / Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Prognostic_studies Language: En Journal: Recent Pat Anticancer Drug Discov Journal subject: NEOPLASIAS / TERAPIA POR MEDICAMENTOS Year: 2017 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google